something me and you share , fun.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Bid and Ask , make you want yo sell , buy high and sell low , that money to water my plant ... When their have flowers , Mjna give your money back with big profit . Buy buy buy
Buy now
Yeah , that all investors are waiting ... Trust , believe and fearless for Mjna stock have to come back ...@25 cents a shr ....help if we all buy buy buy
Should marijuana be a medical option?Standard Site
BUY BUY BUY ...MJNA Before too late...
In 1972, the US Congress placed marijuana in Schedule I of the Controlled Substances Act because they considered it to have "no accepted medical use." Since then, 16 of 50 US states and DC have legalized the medical use of marijuana.
Proponents of medical marijuana argue that it can be a safe and effective treatment for the symptoms of cancer, AIDS, multiple sclerosis, pain, glaucoma, epilepsy, and other conditions. They cite dozens of peer-reviewed studies, prominent medical organizations, major government reports, and the use of marijuana as medicine throughout world history.
Opponents of medical marijuana argue that it is too dangerous to use, lacks FDA-approval, and that various legal drugs make marijuana use unnecessary. They say marijuana is addictive, leads to harder drug use, interferes with fertility, impairs driving ability, and injures the lungs, immune system, and brain. They say that medical marijuana is a front for drug legalization and recreational use.
http://medicalmarijuana.procon.org/
By the time , Mjna has all cash and profit , they increase value their stock , it's may 5$ a shr. buy buy buy
Yep 2$ a share if it goes right , Mjna is have all direction , legal is only one small door . Buy buy buy
Safe, Effective, Natural Medicine
The medical use of the cannabis plant goes back at least 5,000 years to ancient China, where the emperor Shen Nung listed it in his classic pharmacopeia, the Pen Ts'ao. It is also listed in the medical works of India including the famous Hindu surgeon Susruta, and the Roman physicians Pliny and Galen. Most of the herbal guides of the Moslem and European cultures also gave frequent reference to its medical value, and cannabis was one of the world's primary medicines for millenia on end.
Used by most of the world's cultures for its healing properties, there was a tremendous burst of medical research in the 19th century. Cannabis was listed in medical texts of the last century as a treatment for over 100 different health conditions, and Queen Victoria's personal physician wrote in praise of its therapeutic value. When the ban was proposed in 1937, the AMA went before Congress to oppose the law and specifically protested that the Marijuana Tax Act was a fraud because the plant's scientific name is Cannabis sativa, its English name is True Hemp, and no one at the time knew that the ban would affect the essence of medicine, agriculture and industry -- until it was too late.
Access to effective medicine and quality health care are listed as fundamental human rights in the UN Universal Declaration of Human Rights. Medical use is specifically allowed by the Single Convention Treaty. It is cruel to deny sick and dying people this effective medicine and inhumane to punish patients whose very quality of life depends on access to cannabis.
http://www.hr95.org/medicalmarijuana.html
Sector: Agriculture and Forestry
Location: Oakland Ca. USA, United States
Request: Angel Funding
Deal Size: US$2,000,000
Originally, the Emerald Triangle"Unofficial Growers Association, or (UGA)"with over 100 years of combined research and field development in what is today's marijuana industry. For 30 years the UGA has provided the growing community with G1 clone stock for indoor and outdoor production. The UGA, now Cloneworks LLC (a California Corporation), has focused its interests on production of organic medically certified first generation clone stock. Cloneworks LLC is dedicated to the advancement of organic alternative medicines. All clone stock is seed grown in our engineered organic soil and backed by 30 years research in long-term single plant production, resulting in consistent quality medical grade marijuana. It is the intention of Cloneworks LLC to become the largest supplier of medical marijuana to the growing community.
In 2010 the city of Oakland passed a measure to allow licensed commercial production of medical marijuana. Medical marijuana is a thirty eight billion dollar a year industry in the US alone. Today 98% of indoor marijuana is grown from clone stock of questionable origin. With the decriminalization of medical marijuana will be new regulations and standards. To date there has been no place of origin or standard of quality that has been established in the US due to lack of legal facilities. Cloneworks, however, for 30 years has led the industry in production of quality and consistent first generation organic clone stock from its facilities in the Trinity Mountains.
Our goal is to purchase a 35,000 sq. foot indoor processing facility that will be the largest legal medical marijuana production plant in US. This proposed facility will be designed to use energy efficient LED and digital light technology cutting operating costs by over 30% annually in the first year. This facility has approximately 40,000 sq. feet of solar production area capable of producing 200kwh of electricity. Once installed, the power will be sold to the local utility company, reducing operating costs by two thirds annually. In three years this combined technology will make this the most energy efficient, modern facility of its kind in the US.
Once in full production this facility could produce 30,000 clones annually and 20,000 pounds of marijuana. This product will be sold to the 2,000 dispensaries in California as certified organic medical media produced in a licensed production facility. This is the future of government regulation for the industry with regard to interstate commerce, safety, quality and consistency of alternative organic medicine. To date 25% of the United States has already decriminalized medical marijuana making licensed production facilities possible in other states.
Estimated production/values:
Year Two:
• 6000 lbs. Medical grade marijuana/estimated market value: $18,000,000.
• 10,000 first generation organic clone stock/market value: $200,000.
Year Three:
• 12,000 lbs. medical grade marijuana/estimated market value: $36,000,000.
• 20,000 first generation clone stock/market value: $400,000.
Year Four and Five:
• 20,000 lbs. medical grade marijuana/estimated market value: $60,000,000.
• 30,000 first generation clone stock/market value: $600,000.
Cloneworks is seeking investor funds to achieve our goals in three to five years and to take stock public in five to seven years. These funds will provide for startup and expansion in other areas of production as well as new facilities across the country.
Mjna win , I win . Please read some book and join me , "WEED WAR". Good medical ....marijuana medical...Tax on end.
Cancer Bibliography
Books
Cannabis in Medical Practice: A Legal, Historical and Pharmacological Overview of the Therapeutic Use of Marijuana, Mary Lynn Mathre, Ed., McFarland Press (1998).
Marijuana Medical Papers, Tod Mikuriya, M.D. (ed.) Medi-Comp Press, (1972).
Cannabinoids as Therapeutic Agents, Raphael Mechoulam (ed.) CRC Press, (1986).
Cancer Treatment & Marijuana Therapy, Robert C. Randall (ed.), Galen Press, (1990).
Marihuana, The Forbidden Medicine, Lester Grinspoon, M.D. and James B. Bakalar, Yale University Press, (1993).
Marijuana and AIDS: Pot, Politics & PWAs in America, Robert C. Randall, Galen Press, (1991).
Journal Articles
Cancer Treatment Reports, 566, 589-592 (1982).
"Cannabinoids for Nausea," Lancet, January 31, 1981.
Carey, M.P., Burish, T.G., & Brenner, D.E., "Delta-9-THC in Cancer Chemotherapy: Research Problems and Issues," Annals of Internal Medicine, 99, 106-114 (1983).
Chang, A.E. et al. "Delta-9-Tetrahydrocannabinol as an Antiemetic in Cancer Patients Receiving High-dose Methotrexate," Annals of Internal Medicine, 91, 819-824 (1979).
Frytek, S. & Moertel, C.G. "Management of Nausea and Vomiting in Cancer Patients," Journal of the American Medical Association, 245:4, 393-396 (1981).
Harris, L., "Analgesic and Antitumor Potential of the Cannabinoids," The Therapeutic Potential of Marijuana, Cohen & Stillman (eds.), 299-305 (1976).
Harris, L., Munson, A. & Carchman, R "Anti-tumor Properties of Cannabinoids," The Pharmacology of Marihuana, Braude & Szara (eds.), 749-762 (1976).
Neidhart, J., Gagen, M., Wilson, H. & Young, D. "Comparative Trial of the Antiemetic Effects of THC and Haloperidol," Journal of Clinical Pharmacology, 21, 385-425 (1981).
Sallan, S.E., Zinberg, N., & Frei, E. "Antiemetic Effect of Delta-9-THC in Patients Receiving Cancer Chemotherapy," New England Journal of Medicine, 293:16, 795-797 (1975).
Sensky, T., Baldwin, A., & Pettingale, K. "Cannabinoids as Antiemetics," British Medical Journal, 286, 802 (1983).
Ungerleider, J., Andrysiak, T., et. al. "Cannabis and Cancer Chemotherapy: A Comparison of Oral Delta-9-THC and Prochlorperazine," Cancer, 50, 636-645 (1982).
Vinciguerra, V., "Inhalation Marijuana as an Antiemetic of Cancer Chemotherapy," New York State Journal of Medicine, 525-527, (October 1988).
Glaucoma Bibliography
Books
Cannabis in Medical Practice: A Legal, Historical and Pharmacological Overview of the Therapeutic Use of Marijuana, Mary Lynn Mathre, Ed., McFarland Press (1998).
Cannabinoids as Therapeutic Agents, Raphael Mechoulam (ed.) CRC Press, (1986).
Marijuana, Medicine, & The Law, Volumes I&II, R.C. Randall (ed.), Galen Press, (1988-1989).
Marihuana, The Forbidden Medicine, Lester Grinspoon, M.D. and James B. Bakalar, Yale University Press, (1993).
Scientific Journal Articles
Hepler, R.S. & Frank, I. "Marijuana Smoking and Intraocular Pressure," Journal of the American Medical Association, 217, 1392 (1971).
Hepler, R.S., Frank, I. & Ungerleider, J. "Pupillary Constriction After Marijuana Smoking," American Journal of Ophthalmology, 74, 1185-1190 (1972).
Shapiro, D. "The Ocular Manifestation of the Cannabinoids," Ophthalmologica, 168, 366-369 (1974).
Hepler, R.S. & Petrus, R. "Experiences With Administration of Marihuana to Glaucoma Patients," The Therapeutic Potential of Marijuana, Cohen & Stillman (eds.), 63-75 (1976).
Hepler, R.S., Frank, I. & Petrus, R. "Ocular Effects of Marihuana Smoking," Pharmacology of Marihuana, Braude & Szara (eds.), 815-824 (1976).
Perez-Reyes, M., Wagner, D., Wall, M.E. & Davis, K. "Intravenous Administration of Cannabinoids and Intraocular Pressure," The Pharmacology of Marihuana, Braude & Szara (eds.), 829-832 (1976).
Goldberg, I., Kass, M. & Becker, B. "Marijuana as a Treatment for Glaucoma," Sightsaving Review, Winter issue 147-154 (1978-79).
Crawford, W. & Merritt, J.C. "Effects of Tetrahydrocannabinol on Arterial and Intraocular Hypertension," International Journal of Clinical Pharmacology and Biopharmacology, 17, 191-196 (1979).
Merritt, J.C., Crawford, W., Alexander, P., Anduze, A. & Gelbart, S. "Effects of Marijuana on Intraocular and Blood Pressure in Glaucoma," Ophthalmology, 87, 222-228 (1980).
Merritt, J.C., McKinnon, S., Armstrong, J., Hatem, G. & Reid, L. "Oral Delta-9-Tetrahydrocannabinol in Heterogeneous Glaucomas," Annals of Ophthalmology, 12, No 8. (1980).
Zimmerman, T. "Efficacy in Glaucoma Treatment: The Potential of Marijuana," Annals of Ophthalmology, 444-450 (1980).
Merritt, J.C., Perry, D., Russell, D. & Jones, B. "Topical Delta-9-Tetrahydrocannabinol and Aqueous Dynamics in Glaucoma," Journal of Clinical Pharmacology, 21, 467S-471S (1981).
Merritt, J.C., et al. "Effects of Topical Delta-9-Tetrahydrocannabinol on Intraocular Pressure in Dogs," Glaucoma, Jan/Feb., 13-16 (1981).
Merritt, J.C., Olsen, J., Armstrong, J., McKinnon, S. "Topical Delta-9-Tetrahydrocannabinol in Hypertensive Glaucomas," Journal of Pharmacy & Pharmacology, 33, 40-41 (1981).
Merritt, J., Cook, C. & Davis, K. "Orthostatic Hypotension After Delta-9-Tetrahydrocannabinol Marijuana Inhalation," Ophthalmic Research, 14, 124-128 (1982).
Merritt, J. et al. "Topical Delta-8-Tetrahydrocannabinol as a Potential Glaucoma Agent," Glaucoma, 4, 253-255 (1982).
Merritt, J. "Outpatient Cannabinoid Therapy for Heterogenous Glaucomas: Guidelines for Institution and Maintenance of Therapy," Marijuana '84: Proceedings of the Oxford Symposium on Cannabis, 681-683 (1984).
Merritt, J.C., Shrewsbury, R., Locklear, F., Demby, K. & Wittle, G. "Effects of Delta-9-Tetrahydrocannabinol and Vehicle Constituents on Intraocular Pressure in Normotensive Dogs," Research Communications in Substances of Abuse, 7, 29-35 (1986).
Spasticity Bibliography
Books
Cannabis in Medical Practice: A Legal, Historical and Pharmacological Overview of the Therapeutic Use of Marijuana, Mary Lynn Mathre, Ed., McFarland Press (1998).
Cannabinoids as Therapeutic Agents, Raphael Mechoulam (ed.) CRC Press, (1986).
Muscle Spasm, Pain & Marijuana Therapy, Robert C. Randall, Galen Press (1990).
Marihuana, The Forbidden Medicine, Lester Grinspoon, M.D. and James B. Bakalar, Yale University Press, (1993).
Scientific Journal Articles
Borg, J., Gershon, S. & Alpert, M. "Dose Effects of Smoking Marihuana on Human Cognitive and Motor Functions," Psychopharmacologia, 42, 211-218 (1975).
Dunn, M. & Ross, D. "The Perceived Effects of Marijuana on Spinal Cord Injured Males," Paraplegia, 12, 175 (1974).
Hanigan, W.C., Destree, R., Truong, X.T. "The Effects of Delta-9-THC on Human Spasticity," Journal of the American Society of Clinical Pharmacology & Therapeutics, 198 (Feb. 1986).
Manno, J. E., et.al. "Comparative Effects of Smoking Marihuana or Placebo on Human Motor & Mental Performance," Clinical Pharmacology & Therapeutics, 11:6, 808-815 (1970).
Meinck, H.M., et.al. "Effect of Cannabinoids on Spasticity and Ataxia in Multiple Sclerosis," Journal of Neurology, 236:120-22 (1989).
Petro, D. & Ellenberger, C. Jr.. "Treatment of Human Spasticity with Delta-9-Tetrahydrocannabinol," Journal of Clinical Pharmacology, 21:8&9, 413S-416S (1981).
Petro, D. "Marijuana as a Therapeutic Agent for Muscle Spasm or Spasticity," Psychosomatics,21:1, 81-85 (1980).
Sandyk, R., Consroe, P., Stern, L.Z. & Snider, S.R. "Effects of Cannabinoid in Huntington's Disease," Neurology, 36, 342 (1986).
Truong, X.T., & Hanigan, W.C. "Effect of Delta-9THC on EMG Measurements in Human Spasticity," Journal of the American Society of Clinical Pharmacology & Therapeutics, 232 (Feb. 1986).
Weil, A., Zinberg, N. & Nelsen, J. "Clinical & Psychological Effects of Marijuana in Man," Science, 162, 1234-1242 (1968).
Medical Use of Marijuana for Muscular Spasticity
Cannabis (marijuana) has demonstrated particular success in the treatment of muscular spasticity disorders.
In 1839, Dr. William B. O'Shaughnessy was greatly impressed with the plant's muscle relaxant and anti-convulsant properties, stating his belief that in cannabis, "The (medical) profession has gained an anti-convulsive remedy of the greatest value."
An historical account alluding to the use of cannabis in the treatment of spasticity can be found in a March 22, 1890, issue of The Lancet. An article written by Dr. J. Russell Reynolds (physician to Queen Victoria) noted, "There are many cases of so called epilepsy in adults but which, in my opinion (are) the result of organic disease of a gross character in the nervous centers, in which India hemp (cannabis) is the most useful agent with which I am acquainted." Dr. Reynolds may well have been referring to multiple sclerosis (MS). The first written record of MS is noted between 1880-85.
Muscular spasticity is a common condition, affecting more than one million persons in the United States. It afflicts individuals with multiple sclerosis, stroke, cerebral palsy, paraplegia, quadriplegia, and spinal cord injuries. Current medical therapy is woefully inadequate for those individuals suffering from spasticity problems. Phenobarbital and diazepam (Valium) are commonly prescribed drugs but many patients develop a tolerance to these medications, can become addicted to the drug, or complain of heavy sedation.
Dunn and Davis reported in a 1974 issue of Paraplegia magazine that ten patients admitted using marijuana for spinal cord injury, "with perceived decrease in pain and spasticity." These anecdotal and historical accounts of marijuana's effectiveness in treating spasticity have led to a few controlled studies. Dr. Denis Petro and Dr. Carl Ellenberger completed a pilot study of the effects of delta-9 THC on multiple sclerosis patients in 1979. Seven of nine patients responded favorably to treatment with delta-9-THC. Dr. Petro reports hearing from more than one hundred individuals with spasticity problems who report relief from the use of marijuana.
The continued classification of marijuana as a Schedule I drug has greatly impeded research with the drug. Nevertheless, a significant number of studies have been conducted leading Chief Administrative Law Judge Francis Young of the DEA to conclude in September 1988 that marijuana's medical benefits in the treatment of spasticity is "beyond question" and recommended rescheduling of the drug to allow prescriptive access. Unfortunately Judge Young's ruling was rejected by the administrator of the DEA.
Medical Use of Marijuana by Patients with Glaucoma
Glaucoma is an eye disease which afflicts more than four million Americans and is the leading cause of blindness in the United States. According to the National Society for Prevention of Blindness, there are 178,000 new cases of glaucoma diagnosed each year.
Glaucoma can strike people of all ages but is most often found among those over 65. The most common form of glaucoma is chronic or open-angle glaucoma. It is characterized by increased pressure within the eye (intraocular pressure or IOP) which can cause damage to the optic nerve if not controlled effectively. Other types of glaucoma include narrow-angle and secondary. Treatment of narrow-angle glaucoma is primarily surgical. In approximately 90% of the open-angle and secondary glaucomas topical (eyedrop) preparations along with some oral medications can effectively control the disease, but at least 10% of all cases fail to be completely controlled by available prescriptive drugs. In some instances available glaucomic medications can cause side-effects such as headaches, kidney stones, burning of the eyes, blurred vision, cardiac arrhythmias, insomnia, and nervous anxiety. These side-effects may become so severe that the patient must discontinue use.
Marijuana has shown promise as a possible glaucoma treatment in numerous published studies. In controlled studies at UCLA, it was discovered that patients smoking marijuana experienced, on average, a 30% drop in eye pressure. The reduction was dose related and lasted 4 to 5 hours. Dr. Robert Hepler, principal investigator in the UCLA study, concluded that cannabis may be more useful than conventional medications and may reduce eye pressure in a way that conventional medications do not, thus making marijuana a potential additive to the glaucoma patient's regimen of available medication.
Tolerance to conventional medications is a common problem in glaucoma control. The use of marijuana for additional IOP reduction could eliminate the need for surgical intervention. Glaucoma surgery costs Americans an estimated $8.8 million per year.
Scientists have been working to develop a marijuana eyedrop for several years. Until recently, they concentrated on delta-9-THC, marijuana's psychoactive ingredient. Some researchers, however, have begun to wonder if other constituents in the cannabis plant might be more effective in reducing IOP. This theory is bolstered by the few glaucoma patients who have continued, legal access to marijuana. In these cases, synthetic THC is only effective for a short period of time. Natural marijuana, however, consistently lowers IOP.
A number of pharmaceutical companies are investigating drugs that are chemically similar to various constituents of cannabis for possible glaucomic applications. A West Indies pharmaceutical company has developed a synthetic marijuana eyedrop but this is unavailable in the U.S.
Medical Use of Marijuana by Patients Undergoing Cancer Chemotherapy or afflicted with AIDS
Cancer chemotherapy can often prolong the patient's life by several years. In some instances, a complete "cure" can be obtained. Unfortunately, these drugs also have severe side-effects, most notably nausea and vomiting. Patients sometimes find these effects so distressing they abandon chemotherapy entirely.
People with AIDS (Acquired Immune Disease) also experience these problems. Powerful anti-viral drugs such as AZT and the new protease inhibitors can induce severe nausea, vomiting, and other gastrointestinal effects. Similarly, AIDS "wasting syndrome" can literally starve an individual to death.
Investigations with cannabis have revealed its ability to reduce (or eliminate) the nausea and vomiting associated with chemotherapy while also providing an appetite stimulus. The benefits are thus twofold: 1) the patient is able to retain food and maintain body strength, and 2) he or she can tolerate the life-prolonging chemotherapy treatments.
At least eight published studies have confirmed the ability of cannabis and its psychoactive ingredient delta-9-THC to reduce nausea and vomiting. The first appeared in 1975 in The New England Journal of Medicine. It concluded, "THC is an effective anti-emetic for patients receiving cancer chemotherapy."
The Food and Drug Administration (FDA), in February, 1980 listed 33 studies of cannabis and nausea and vomiting. Most of these experiments involve efforts to determine the proper dosage of THC and several are comparative studies with other standard anti-emetics.
In New Mexico, a state sponsored study has shown the cannabis cigarette to be 30% more effective than THC in relieving nausea and vomiting. Another study, sponsored by the National Cancer Institute (NCI), discovered that inhaled cannabis resulted in a 71% efficacy rate, as opposed to 44% with oral delta-9-THC. These controlled studies have been fortified by "anecdotal" accounts from individuals who have abandoned legal access to THC because they prefer marijuana obtained illegally. These patients report that smoking marijuana seems to bring an almost instantaneous relief.
This is not a new finding. As early as May 1978, researches at a symposium sponsored by the National Cancer Institute (NCI) concluded, "All in all, the cigarette may be the best means of administering the drug."
In September 1988 the chief administrative law judge of the Drug Enforcement Administration ruled that marijuana has medical value in the treatment of side-effects caused by cancer chemotherapy. His decision was over-ruled by the administrator of the DEA and marijuana remains illegal for medical purposes.
General History
Cannabis sativa and cannabis indica (marijuana) has a long and distinguished history as a medicinal herb. The Chinese emperor Shen-nung was the first to record the medical use of cannabis in 2737 B. C. Many cultures, however, have recognized the therapeutic benefits of the cannabis plant. Among them are: India, Persia, Assyria, Greece, Africa, South America, Turkey, and Egypt.
In Western medicine cannabis enjoyed its heyday during the 19th Century. In the late 1830s, Dr. William B. O'Shaughnessy, a British physician at the Medical College of Calcutta, learned of cannabis and began experimenting with various cannabis preparations. He determined the drug was safe and effective in treating rabies, rheumatism, epilepsy and tetanus.
O'Shaughnessy published his studies in a forty page article entitled "On the preparations of the Indian Hemp or Gunjah," in 1839. This marked the beginning of an intensive period of study throughout Europe and America. More than 100 articles were published between 1840 and 1900. Many prominent physicians, including Queen Victoria's personal physician, J. R. Reynolds, studied cannabis. Reynolds declared it "by far the most useful of drugs" in treating "painful maladies."
In America, the first extensive study of cannabis in medicine was completed in 1860 by the Ohio Medical Society. Physicians reported success in treating stomach pain and gastric distress, psychosis, chronic cough, gonorrhea and neuralgia.
At the turn of the century, the drug began to fall into disuse. Cannabis was difficult to store and its extracts were variable in their effect. As new drugs were developed in the early 1900s, cannabis was less widely used but still available by prescription and in some over-the-counter preparations.
The Marijuana Tax Act of 1937, intended to prohibit marijuana's social use, was most effective in prohibiting medical use of the drug. Strict regulations governing cultivation of the plant made its production impractical. New synthetic drugs caught the fancy of physicians and cannabis was used less frequently, Finally, in 1942, the Federal Bureau of Narcotics convinced the U. S. Pharmacopeia to remove the drug from its listing.
In the 1970s, cannabis was "re-discovered" as a medical substance. Controlled studies have revealed its therapeutic utility in the treatment of cancer chemotherapy side-effects, glaucoma, and spasticity ailments. Federal regulations continue to make research with the drug very difficult, however, and many promising areas of therapeutic application have received little or no attention. These include: asthma, AIDS, epilepsy, analgesic action, tumor retardation, nervous disorders, and mental illness.
Medical Marijuana and Traditional Chinese Medicine
June 21, 2010 by artesianspringom
It’s becoming a trend across the United States – the use of marijuana for medicinal purposes. Here in Colorado, this is a pretty hot topic. It is a big time business. Some of the local dispensaries are grossing somewhere between $300,000 to $500,000 a month. So there is definitely a market for the herb and local MD’s are starting to take notice.
Advocates of Medical Marijuana believe that it can help treat a variety of issues.
Because I am practitioner of Traditional Chinese Medicine, I have had some questions directed toward me about whether or not I can provide marijuana to my patients. The simple answer is no. I am not legally able to dispense marijuana.
However, I have learned that marijuana is certainly part of the Chinese Materia Medica. My sources of information being both Master Yun Xiang Tseng and Dr. Li Gou Yong. Dr. Li is a very well known in China as a 17th generation herbal doctor in the family lineage of Li Shi Zhen. (Li Shi Zhen wrote “the Bible of Chinese Herbal Medicine” called the Ben Cao Gan Mu.)
In TCM, marijuana is known as Da Ma. Da Ma is difficult to purchase in China because it is considered to be poisonous. According to TCM theory, it restrains the functions of Brain Marrow and Fluids. This means that it will suppress the functions of the Central Nervous System. It is also has very strong Qi dispersing action. This means that if a person is already ill, it could potentially make for more problems. It also clouds the Shen, thus dulls a person’s spirit.
This doesn’t mean that Da Ma has no therapeutic effects. According to Dr. Li it can be useful for treating chronic cough, chronic diarrhea, hemorrhoids, anal prolapse, colitis, promoting digestive function, alleviating pain, and calming the mind for sleep. However, in Traditional Chinese Herbal Medicine, Da Ma is never used alone. It is always used in combination with other herbs to create a synergistic effect and remove or reduce the nastier side effects. Da Ma is also only used in extremely small doses because of its potency. As with the majority of Chinese Herbal Medicines, Da Ma works best when ingested. That means either brewing it into an herbal infusion and drinking the decoction or just plain eating it. According to Dr. Li, smoking the herb is hazardous. When smoked Da Ma releases its poison directly into the Lungs and does more harm than good.
So what are my personal feelings on the subject of Medical Marijuana? I believe that if it can be of truly therapeutic service for a patient, then it should be used in the fashion that the law provides. However, it seems to me that many folks out there are manipulating their doctors just so that they can get high. That is not therapy. That is recreation. For me, I consider this situation similar to that of alcohol. Alcohol has some great therapeutic properties, but when imbibed for recreation it is ultimately destructive to the body. A patient should only use medical marijuana for the purposes of therapy. Otherwise, they will create imbalances in their body which eventually will lead to harm.
What about you? Have you had positive or negative experiences with medical marijuana? I’d love to hear what you’ve got to say on the subject. Please feel free to comment.
http://artesianspringom.wordpress.com/2010/06/21/medical-marijuana-and-traditional-chinese-medicine/
Putting a Buzz into Chewing Gum
by MARY KRASN on AUGUST 10, 2012
Juicy Fruit and Doublemint gum, step aside. You’ve got competition. One that chewing gum makers will be buzzing about.
Medical Marijuana Inc. (OTC: MJNA), a San Diego based hemp producer, will introduce the first marijuana-based chewing gum in selected states next month. The gum is intended not to get customers high, but to ease their pain. The company claims its CanChew gum helps relieve pain, muscle cramps and nausea, and is heralding the product as a breakthrough in the management of chronic pain.
“Unfortunately, in the last 30 years, there has been absolutely nothing new in pain killing products,” said the director of CanChew Biotechnologies, Dr. George Anastassov, in a recent interview on Small Cap Voice’s internet radio network.
“Current drugs have many dangers,” says Anastassov, who predicts the widely used opioid painkiller Vicodin will be taken off the market because it causes liver damage. “Opioids have been a tremendous social burden, causing thousands of deaths each year.”
Anastassov, a physician and dentist, says the idea of a hemp-based chewing gum “started as a joke” between himself and his co-inventors as they contemplated various delivery systems to ease pain through marijuana.
“Cannabinoids do not cause liver damage or injury,” said Anastassov. “But smoking is harmful, period, and smoking marijuana causes further injury to patients who are already immune-suppressed. Oral sprays such as Sativex also have side effects. We wanted to safely deliver a 99.9 percent pure and unadulterated product.”
The company says it will soon begin clinical studies in Europeon the safety and efficacy of CanChew gum in the treatment of pain and nausea.
“The delivery of these hemp extracts via the oral mucosa provides for rapid and near complete absorption directly into the body’s systemic circulation,” says the company. “The cannabinoids in CanChew are also processed with the saliva during the chewing process. Cannabinoids then enter the digestive tract and are processed in a slower, less aggressive manner. This gives the user a time-release factor which allows for benefits of the CanChew gum to extend for several hours.”
Medical Marijuana recently bought a 50% stake in CanChew Technologies, which is based in theNetherlands. It will release CanChew gum as an over-the-counter product in mid-September in Colorado, California, Arizona and Washington D.C., where medical marijuana is legal. The gum will be released in international markets in early 2013.
“I think we have developed a revolutionary product,” claims Anastassov, who says the medical benefits of marijuana have been recognized for 2,000 years. “We’re just tapping the possibilities for cannabinoids in chewable form. The opportunities are limitless at this point.”
Keep buying , I go to the beach . Have good weekend all . Mjna may have some news for ya this weekend . Buy buy buy next monday hot again.
10cents a shr Mjna go ... Buy buy buy
I buy more today , mjna is one time chance . Talk too much not help , buy with me is better . Buy buy buy ...fearless baby.
You need to take some sleep. It grows by it self , real money grows on Mjna ... Big tree baby . Mjna green at least 20% today ..... Buy buy buy
caption: Agricultural Facility "4" Raw Land with Hemp Planted 3 Weeks Prior. (PRNewsFoto/Medical Marijuana Inc.)
source: MEDICAL MARIJUANA INC.
news release: Medical Marijuana Inc. Provides Update on Industrial Hemp…
media contact info: Medical Marijuana, Inc., 888-682-6562.
release date: 09 August 2012 EDT
release time: 10:47 EDT
city: SAN DIEGO
state: CA
country: UNITED STATES
tags: HEALTH
direct link to this photo: http://photos.prnewswire.com/prnh/20120809/NE55003-a
I ended up going with the Bubble Star at the budtender's suggestion ("I like that one") and the Flo due to the potent smell and crystal-coated buds. Nothing in the Herbs4You cabinet goes for more than $30 for four grams, with most strains selling at $25 (At least, that is what I understood from my budtender). Pre-weighed ounces packed tight in Mason jars were selling for between $140 and $170 -- including the stinky (but extremely leafy) Flo. Pre-weighed $20 grams of strain-specific bubble hash are kept on top of the counter in baggies hanging from a rotating display and $25 grams of BHO were just below on a counter's glass shelf. The BHO had a really wet look to it that didn't jibe with my sensibilities as much as the crumbly, waxy-looking bubble hash did, though.
I left with just over an eighth of herb and a gram of hash for under $49 after taxes. And though a good amount of the selection was not up to standards, it's worth the nose full of air freshener to check out the shop for those three or four strains being done right .
http://blogs.westword.com/latestword/2012/08/medical_marijuana_dispensary_review_herbs4you_denver.php
MJNA making money ...cash cash cash ... BUY BUY BUY
Real loser sell today , they buy back tomorrow and feel sorry a little . MJna will green more 20% on friday . Buy Buy Buy ... Jack is getting closer to Goal.....
Keep selling , I like it .... Wait I buy last chance for me to buy more , sky ... Rocket mjna
Vol is good , market good , MJNA is best company . Some pay tax cause their trade , I pay tax when it 2$ a shr . They mess the Mjna stock chart for reason my friend . Test your honor with MJNA ... Buy buy buy
I have 50k like you my friend , but 40$ a share we happy right? Fun and Buy buy buy
Oh man ... I fold from my chair hahaha good work , i like that funny and get rich . Mjna is interesting ... Still buy buy buy .... Lol
Mjna have a lot of cash ... 2$ a share , Buy Buy Buy
Keep selling , I buy all ... I am all in Mjna ..., buy buy buy .. Party at my house .
500k in 2 mins , boom go Mjna , buy now is not late yet... Buy buy buy
Keep hold this S""t , tell your grand children " buy after known ". you stuck and suck. Pam and scam , d and p . HOLD an buy more for bigger stupid and mistake . HESG
Not thing will on MJNA , 2$ a share ...BUY BUY BUY
Since May 2011, medical marijuana cardholder numbers have nosedived, dropping to less than a third of the total then.
A more restrictive 2011 state law, Senate Bill 423, that made it more difficult to qualify for a so-called “green card” and for providers to qualify to grow and sell marijuana legally.....
Voters in November will have a chance to reject or retain the 2011 law when they vote on Initiative Referendum 124.
“We hope that the voters will reject the current law by rejecting IR-124 at the ballot, and demand that the legislature provide us with a better set of regulations that will help both communities and patients alike,” Lindsey said.
http://helenair.com/news/local/state-and-regional/medical-marijuana-cardholders-increase-slightly/article_d808caa0-e1e4-11e1-852e-001a4bcf887a.html
SUPPORT MJNA WITH HISTORY:
History of Cannabis in Ancient China
Cannabis Sativa is an old plant with a long history.
Published on May 10, 2011 by Jann Gumbiner, Ph.D. in The Teenage Mind
Cannabis Sativa is an old plant with a long history. The word, sativa, comes from Latin and means "sown" or "cultivated." And, in fact, the hemp plant, Cannabis Sativa, has been cultivated by humans for thousands of years. Cultivated primarily for its strength as a fiber and for its medicinal uses, it has even been grown for food. Some of the earliest archeological hemp evidence, about 10,000 B.C., comes from rope imprints on broken Chinese pottery. Fragments of hemp cloth have also been found in Chinese burial chambers dating from the Chou Dynasty (1122-249 B.C.). In addition to archeological evidence, written documents refer to hemp as a source of clothing. For example, The Shu King, a book dating to about 2350 B.C., refers to the soil in Shantung as rich with silk and hemp while ancient poetry mentions young girls weaving hemp into clothing (Abel, 1980).
The Chinese also relied on hemp for warfare. Due to its strength and durability Chinese archers made bowstrings from hemp. Because these hemp bowstrings were stronger than the enemy's bamboo ones, the Chinese arrows could fly further. This was a large advantage in war. In fact, hemp was so important that Chinese monarchs allocated large portions of land specifically for growing hemp - the first war crop.
Related Articles
Marijuana as Medicine?
History of Cannabis in India
Not Your Typical Zombies and Spice
Cannabis and Creativity
Is Marijuana Addictive?
Find a Therapist
Search for a mental health professional near you.
Find Local:
Acupuncturists
Chiropractors
Massage Therapists
Dentists
and more!
Then, there is paper. Yes, paper. Paper is probably one of the most significant Chinese inventions. Fragments of paper containing hemp fiber have been found in Chinese graves dating to the first century B.C. The Chinese made paper by crushing hemp fibers and mulberry tree bark into a pulp and putting the mixture into a tank of water. The tangled fibers rose to the top of the water, were removed, and placed in a mold. After drying, the fibers formed sheets that could be written on. The Chinese kept paper making a secret for many centuries. Eventually the secret became known to the Japanese during the 5th century A.D. and finally to the Arabs through Chinese prisoners in the 9th century. For some fascinating images of this ancient Chinese craft of paper making follow this link http://wikis.lib.ncsu.edu/index.php/Chinese_Invention_of_Paper_and_Papermaking_-_Sam_Lipes_and_Travis_Bernard.
So, the Chinese used the hemp plant for rope, clothing, bowstrings, paper and of course, medicine. The ancient emperor, Shen-Nung (c.2700 B.C.), is known as the Father of Chinese Medicine. Because he was a good farmer and concerned about his suffering subjects, he looked to plants for cures. According to legend, Shen-Nung tried poisons and their antidotes on himself and then compiled the medical encyclopedia called, Pen Ts'ao. The Pen Ts'ao list hundreds of drugs derived from vegetable, animal and mineral sources. Among these drugs is the plant cannabis, "ma."
Ma was a unique drug because it was both feminine, or yin, and masculine, or yang. Yin represented the weak, passive, and negative female influence in nature while yang represented the strong, active, and positive male force. When yin and yang were in balance, the body was in harmony and healthy. When yin and yang were out of balance, the body was in a state of disequilibrium and ill. Realizing that the female plant produced more medicine, the Chinese cultivated it instead of the male plant. Ma was used to treat absences of yin, such as: female weaknesses (menstruation), gout, rheumatism, malaria, beri-beri, constipation, and absentmindedness (Abel, 1980).
During the second century A.D., the Chinese surgeon, Hua T'o, began to use cannabis as an anesthesia. He combined cannabis resin with wine (ma-yo) and used it to reduce pain during surgery. He performed painful organ drafts, resectioning of the intestines, loin incisions, and chest incisions while the patient was anesthetized with ma-yo.
Cannabis was a mulitipurpose plant to the ancient Chinese. It has been cultivated and used for over 4000 years. It was used for war, writing, food, and medicine but there is very little mention of its psychoactive properties by the Chinese. It wasn't until India came upon cannabis that it became a widespread religious and medicinal intoxicant.
References
Abel, E.L. (1980). Marijuana, The First Twelve Thousand Years. New York: Plenum Press.
http://chineseculture.about.com/library/clipart/blscliparts.htm
N.J. medical marijuana patients can get ID
A registration card costs $200 and is valid for two years. Patients on assistance programs, such as Medicare or Medicaid, will pay $20.
http://www.philly.com/philly/news/local/20120809_N_J__medical_marijuana_patients_can_get_ID_cards_this_week.html
We are on the way up MJNA , BUY BUY BUY .
How much for a gum? $1???big time in this month before Aug 30 . Buy Mjna Buy Buy buy
wow.. Sleep well Doc K , You work hard today . I still buy more tomorrow , can wait any longer . All in MJNA ...BUY BUY BUY
As China has been using a written script for over 4,000 years, one might think that documenting their historical use of Medical Cannabis would be an easy task. However, from a historian’s standpoint, this has proven to be one of the most challenging of sections yet attempted. Granted, were our purpose here simply to establish or document the Industrial uses of the Hemp Plant (as a source of food, cloth, oil, paper etc.), due to the vast amount of archeological evidence, this indeed would have been an easy task.
But what about its medical uses? Recalling that our main purpose here is not simply to repeat what other websites are saying; ---But to actually present the reader with first hand documentation. Actual proof (not just here-say) that such and such actually occurred. Something that (say) a newspaper reporter would feel comfortable using as a source of information for their stories. And this is proving to be no easy task. For example, according to the "Yearbook [1913] of the United States Department of Agriculture"
http://antiquecannabisbook.com/chap2B/China/China.htm
BISMARCK, N.D. — A proposal to allow North Dakotans to use marijuana as medicine puts the Health Department in charge of vetting the business plans of dispensaries, checking home pot gardens and reviewing the drug's labeling and potency.....
Supporters of the medical marijuana initiative turned in about 20,000 signatures to Secretary of State Al Jaeger this week, seeking to put the proposed state law directly on the November ballot. Jaeger has about a month to review the petition, which needs at least 13,452 valid signatures from North Dakota voters to qualify for a statewide vote.
http://www.therepublic.com/view/story/3f0326c215e546bbb00e6503fb848f44/ND--Medical-Marijuana
MJNA is in business :
Medical marijuana in Casa Grande: Scottsdale firm wins lottery
Several hurdles remain before dispensary opens
By BILL COATES
Valley Life Editor
Published: Wednesday, August 8, 2012 9:24 AM MST
Print | E-mail | Comment (No comments posted.) | Rate | Text Size | Share
Medical Pain Relief Inc.’s number came up Tuesday in a lottery for a medical marijuana dispensary in Casa Grande. Medical Pain Relief, a Scottsdale nonprofit, was one of four applicants in the drawing for a dispensary in the Casa Grande area.
The Arizona Department of Health Services will allow one dispensary for each of 126 Community Health Analysis Areas spread throughout the state. CHAA No. 99 covers the Casa Grande area.
You can read the rest of this article in our e-Edition or start a home delivery subscription.
Feds Should Allow Medical Marijuana
FRESH TALK
Drug Paradox: State, federal discrepancy threatens legal users
Yamileth Bolanos, a liver transplant recipient, two-time cancer survivor… (Getty Images )
August 07, 2012|By SAM TRACY | OTHER OPINION
Starting on Oct. 1, medical marijuana will be legal in Connecticut. Although our state's medical marijuana law was carefully designed to minimize the risk of federal invention, the legal reality is that the federal government can still prosecute anyone growing, selling or even using marijuana in compliance with state law. Our state leaders should act to protect Connecticut's citizens, and call on President Barack Obama to allow medical marijuana at the federal level.
http://articles.courant.com/2012-08-07/news/hc-op-tracy-fresh-talk-pol-0808-20120807_1_medical-marijuana-safe-access-oaksterdam-university
California Congresswoman Introduces ‘Medical Marijuana Property Rights Protection Act’
August 7, 2012
By Paul Armentano, NORML Deputy Director
United States Congresswoman Barbara Lee (D-CA), along with eight co-sponsors, has introduced legislation — House Bill 6335, the Medical Marijuana Property Rights Protection Act — which seeks to amend the federal Controlled Substances Act so as to “exempt real property from civil forfeiture due to medical-marijuana-related conduct that is authorized by State law.”
Representative Lee’s bill, the first of its kind ever introduced in Congress, is a direct response to Justice Department’s increased and arbitrary use of the civil asset forfeiture statute to sanction property owners whose tenants are in compliance with state medical marijuana laws. Since October, US Attorneys in California alone have sent more than 300 threatening letters to landlords across the state, resulting in the closure of more than 400 dispensaries, according to tabulations compiled by the group Americans for Safe Access.
Speaking in support of the proposal, Rep. Lee explained, “As a long-time supporter of the rights of patients to have safe and legal access to medicine that has been recommended to them by their doctors, this bill will provide clarification to California businesses and security for California patients. The people of California have made it legal for patients to have safe access to medicinal marijuana and, as a result, thousands of small business owners have invested millions of dollars in building their companies, creating jobs, and paying their taxes. We should be protecting and implementing the will of voters, not undermining our democracy by prosecuting small business owners who pay taxes and comply with the laws of their states in providing medicine to patients in need.”
The Medical Marijuana Property Rights Protection Act has been assigned before the House Judiciary Committee and the House Committee on Energy and Commerce. You can contact your member of Congress is support of the Act via NORML’s ‘Take Action Center’ here.
Several other marijuana law reform bills also remain pending before Congress, including:
* HR 2306, the Ending Federal Marijuana Prohibition Act, which prohibits the federal government from prosecuting adults who use or possess marijuana by removing the plant and its primary psychoactive constituent, THC, from the five schedules of the United States Controlled Substances Act of 1970. The measure presently has 20 co-sponsors. You can contact your member of Congress in support of this Act here.
* HR 1983, the States’ Medical Marijuana Patient Protection Act, which ensures that medical cannabis patients in states that have approved its use will no longer have to fear arrest or prosecution from federal law enforcement agencies. The measure presently has 22 co-sponsors. Support this measure by clicking here.
* HR 1831, the Industrial Hemp Farming Act, excludes low potency varieties of marijuana from federal prohibition. The measure presently has 33 co-sponsors. Its just introduced Senate companion bill, S 3501, has three co-sponsors. Contact your member of the House and Senate in support of this Act here.
* HR 6134, The Truth in Trials Act, provides an affirmative defense in federal court for defendants whose actions were in compliance with the medical marijuana laws of their state. The measure presently has 22 co-sponsors. You can support this measure here.
http://cannabis.hawaiinewsdaily.com/2012/08/07/california-congresswoman-introduces-medical-marijuana-property-rights-protection-act/